Elevated sHLA-G plasma levels post chemotherapy combined with ILT-2 rs10416697C allele status of the sHLA-G-related receptor predict poorest disease outcome in early triple-negative breast cancer patients

INTRODUCTION: Triple negative breast cancer (TNBC) shows an aggressive growing and spreading behavior and has limited treatment options, often leading to inferior disease outcome. Therefore, surrogate markers are urgently needed to identify patients at high risk of recurrence and more importantly, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoffmann, Oliver, Wormland, Sebastian, Bittner, Ann-Kathrin, Hölzenbein, Julian, Schwich, Esther, Schramm, Sabine, Rohn, Hana, Horn, Peter A., Kimmig, Rainer, Kasimir-Bauer, Sabine, Rebmann, Vera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239857/
https://www.ncbi.nlm.nih.gov/pubmed/37283737
http://dx.doi.org/10.3389/fimmu.2023.1188030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239857/
https://www.ncbi.nlm.nih.gov/pubmed/37283737
http://dx.doi.org/10.3389/fimmu.2023.1188030

Ejemplares similares